| pubmed-article:16613680 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C0007600 | lld:lifeskim |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C0152018 | lld:lifeskim |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C1518174 | lld:lifeskim |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C0162388 | lld:lifeskim |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:16613680 | lifeskim:mentions | umls-concept:C0906802 | lld:lifeskim |
| pubmed-article:16613680 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16613680 | pubmed:dateCreated | 2006-4-14 | lld:pubmed |
| pubmed-article:16613680 | pubmed:abstractText | Tyrosine kinase mediates cell proliferation and differentiation, and plays important roles in tumorigenesis and development of esophageal carcinoma. STI571 is a tyrosine kinase inhibitor of platelet-derived growth factor receptor beta (PDGFR-beta) which is overexpressed in esophageal carcinoma. This study was to explore the in vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T. | lld:pubmed |
| pubmed-article:16613680 | pubmed:language | chi | lld:pubmed |
| pubmed-article:16613680 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16613680 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16613680 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:16613680 | pubmed:issn | 1000-467X | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:LoanJ PJP | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:SuXiao-DongXD | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:RongTie-HuaTH | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:WenZhe-ShengZ... | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:ZhangLan-JunL... | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:ZhangPeng-Yua... | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:LiBao-JiangBJ | lld:pubmed |
| pubmed-article:16613680 | pubmed:author | pubmed-author:ZhaoJin-MingJ... | lld:pubmed |
| pubmed-article:16613680 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16613680 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:16613680 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16613680 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16613680 | pubmed:pagination | 456-60 | lld:pubmed |
| pubmed-article:16613680 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:meshHeading | pubmed-meshheading:16613680... | lld:pubmed |
| pubmed-article:16613680 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16613680 | pubmed:articleTitle | [In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T]. | lld:pubmed |
| pubmed-article:16613680 | pubmed:affiliation | State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China. | lld:pubmed |
| pubmed-article:16613680 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16613680 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:16613680 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
